However, survival stratified by PD-L1 was only insignificant or marginally significant.
← all excerpts
Checkpoint molecule PD-1-assisted CD8<sup>+</sup> T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.
1
—
—